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in any medium, provided the original work is properly citeNatural variation for LPS-induced lethal inflammation in mice is useful for
identifying new genes that regulate sepsis, which could form the basis for
novel therapies for systemic inflammation in humans. Here we report that
LPS resistance of the inbred mouse strain SPRET/Ei, previously reported to
depend on the glucocorticoid receptor (GR), maps to the distal region of the
X-chromosome. The GR-inducible gene Tsc22d3, encoding the protein Gilz and
located in the critical region on the X-chromosome, showed a higher expressed
SPRET/Ei allele, regulated in cis. Higher Gilz levels were causally related to
reduced inflammation, as shown with knockdown and overexpression studies
in macrophages. Transient overexpression of Gilz by hydrodynamic plasmid
injection confirmed that Gilz protects mice against endotoxemia Our data
strongly suggest that Gilz is responsible for the LPS resistance of SPRET/Ei mice
and that it could become a treatment option for sepsis.INTRODUCTION
Sepsis, a common systemic inflammatory reaction to microbial
infections, imposes a huge social and economic burden on
healthcare systems and remains associated with very high
mortality rates (40–60%) (Vincent et al, 2006). Despite decades
of intensive research and numerous clinical trials, only few new
therapies are relatively beneficial, and current management of
sepsis relies mainly on supportive treatments (Riedemann et al,, Ghent, Belgium
nt University, Ghent,
elgium
ics, Ghent University,
, Section of Pharma-
-93313609;
rship.
Ltd on behalf of EMBO. This
C BY 3.0), which permits u
d.2003). Thus, there is an urgent need for new therapeutic targets
for the treatment of this condition.
Several mouse models of sepsis have been developed,
ranging from exogenous administration of pathogens or toxins,
such as lipopolysaccharide (LPS), to surgical procedures such as
cecal ligation and puncture (CLP) (Dejager et al, 2011). Injection
of LPS, a component of the outer leaflet of the outer membrane
of Gram-negative bacteria, reproducibly mimics many of the
pathophysiologic manifestations of sepsis (Schultz & van der
Poll, 2002).
We have been studying the mouse strain SPRET/Ei, derived
from Mus spretus, to find new molecular players in LPS-induced
inflammation. Among their many different phenotypes (Dejager
et al, 2009), SPRET/Ei (S) mice exhibit a remarkable resistance to
LPS (Dejager et al, 2010b; Mahieu et al, 2006) and to Gram-
negative infections (Dejager et al, 2010a) compared to the
commonly used laboratory mouse strain, C57BL/6 (B). These
phenotypes make this strain useful for identifying newmolecular
targets for the treatment of sepsis. In addition, because Mus
spretus had diverged fromMusmusculus at least 1.5million years
ago (Guenet & Bonhomme, 2003), SPRET/Ei mice possess a
larger degree of genetic polymorphisms than the commonis an open access article under
se, distribution and reproduction
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searching for the genetic variants responsible for the interesting
characteristics of this mouse strain (Dejager et al, 2009).
We previously reported the resistance of SPRET/Ei mice to
LPS as a dominant trait (Mahieu et al, 2006) and its strong
dependence on the anti–inflammatory actions of the glucocor-
ticoid receptor (GR) (Dejager et al, 2010b). Glucocorticoids
(GCs) are potent anti-inflammatory agents frequently used to
treat inflammatory diseases, such as asthma (Rhen & Cidlowski,
2005). However, the beneficial effect of GCs in sepsis remains
controversial, so GCs are mainly used to limit the use of
vasopressors and to counterbalance adrenal insufficiency. By
binding to the GR, GCs modulate the immune response by
transrepression (TR) of key inflammatory transcription factors,
such as NFkB, and by transactivation (TA) of anti-inflammatory
genes containing glucocorticoid responsive elements (GRE)
(Ayroldi & Riccardi, 2009). For example, the prominent role of
the GC-induced GRE-gene Dusp1 (encoding dual specific
phosphatase 1) in the control of excessive inflammation has
been confirmed in Dusp1 deficient mice, which are very
sensitive for LPS and TNF-induced lethal inflammation
(Vandevyver et al, 2012; Zhao et al, 2005) and in other sepsis
models (Frazier et al, 2009; Hammer et al, 2010). Another
important anti-inflammatory GRE gene is Tsc22d3 (TSC22
domain family member 3), also known as Gilz (glucocorticoid-
induced leucine zipper) (D’Adamio et al, 1997). Gilz mimics
many of the anti-inflammatory actions of the GR in vitro
(Ayroldi & Riccardi, 2009; Beaulieu & Morand, 2011). The
anti-inflammatory actions of Gilz were recently confirmed in
several inflammatory diseases, i.e. inflammatory bowel
disease (Cannarile et al, 2009), rheumatoid arthritis (Beaulieu
et al, 2010) and multiple sclerosis (Srinivasan & Janardhanam,
2011), but the role of Gilz in endotoxemia and sepsis is
unknown.
The objective of this study was to map the loci and to identify
the gene(s) underlying the LPS resistance of SPRET/Ei mice,
using linkage analysis of 140 backcross mice derived from a
cross between (BxS)F1 (,) and C57BL/6 (<) (BSB backcross),
followed by a candidate gene approach. We identified two
quantitative trait loci (QTL), of which one mapped on the X
chromosome (60-70cM). We hypothesized that Tsc22d3,
encoding the protein Gilz, underlies the X-located QTL because
the LPS resistance of SPRET/Ei mice depends on GR activity
(Dejager et al, 2010b) and its anti-inflammatory properties.
Expression and functional studies, in macrophages as well as
in vivo, suggested Gilz as the primary candidate for explaining
the LPS-resistance in SPRET/Ei mice and as an important novel
protective factor in endotoxemia.RESULTS
The extreme LPS resistance of SPRET/Ei mice maps to the
distal region of the X chromosome
To identify the loci responsible for the LPS resistance of SPRET/
Ei mice, we analyzed a backcross population of 140 mice
obtained by crossing (BxS)F1 hybrid females with C57BL/6EMBO Mol Med (2013) 5, 456–470 males. We injected the parental lines, the (BxS)F1 hybrid
and the 140 offspring with 250mg of LPS and followed
mortality for five days. Both the parental SPRET/Ei mice and
the (BxS)F1 hybrid showed increased LPS resistance, which is
consistent with the dominant inheritance of SPRET/Ei LPS
resistance previously reported (Dejager et al, 2010b; Mahieu
et al, 2006).
All 140 offspring, of which 90 (64%) survived the LPS
challenge, were genotyped using 87 microsatellite markers
evenly distributed over the genome, followed by a genome-wide
linkage analysis. The genome-wide significance threshold for
detection of QTL co-segregating with LPS resistance was set at
P¼ 0.05, corresponding with a threshold of (–log10(P)¼ 3.086)
(Li & Ji, 2005). Two genome-wide significant QTL were
identified, one on chromosome 2 (marker D2Mit510 at
65 cM; –log10(P)¼ 3.49, Wald test) and one on the X
chromosome (marker DXMit135 at 69 cM; –log10(P)¼ 3.4,
Wald test) (Fig 1A), spanning a 10cM interval. Linkage analysis
performed for both sexes separately resulted in identical QTL,
though, at lower significance (Supporting Information Fig. S1B).
At both QTL, the presence of a SPRET/Ei allele inferred an
increase in LPS resistance. Both QTL did not exhibit epistasis,
suggesting that each QTL contributed additively to the survival
rates (Supporting Information Fig. S1A).
When (BxS)F1 hybrid mice were injected with different doses
of LPS, the females (carrying a SPRET/Ei X chromosome)
showed better survival (500mg LPS, p¼ 0.03 and 750mg LPS,
p¼ 0.05) than the males (carrying the C57BL/6 X chromosome).
This confirms the strong involvement of the X chromosome in
the LPS resistance of SPRET/Ei mice and the dominant mode of
inheritance of this trait. (BxS)F1 females also suffered less from
LPS-induced hypothermia (Fig 1B) and produced less IL6
(p¼ 0.0014) (Fig. 1C) and other cytokines and chemokines
(Fig 1D) than (BxS)F1 males, which indicates that they are less
sensitive to acute endotoxemia. In addition, the increased LPS
resistance of the (BxS)F1 females was also reflected at the level
of macrophages as LPS-stimulated bone-marrow derived
macrophage cultures (BMDM) derived from female (BxS)F1
mice displayed significantly less IL6 production compared to
BMDM from (BxS)F1 males (p¼ 0.0043), which, in turn, had
less cytokine production compared to BMDM from C57BL/6
mice (p¼ 0.0008) (Fig 1E). In conclusion, (BxS)F1 females are
more resistant to endotoxemia than (BxS)F1 males, which is
compatible with a protective role of the SPRET/Ei X chromo-
some against endotoxemia.
(SxB)F1 and (BxS)F1 males are genetically identical except
for their X and Y chromosomes and some imprinted genes.
When these F1 mice were injected with 500mg of LPS, the
(SxB)F1 mice (carrying a SPRET/Ei X chromosome) displayed
better survival (p¼ 0.027), smaller drop in body temperature
(Fig 1F) and lower production of IL6 production (p¼ 0.0014)
(Fig 1G) than the (BxS)F1 mice. These results confirm again the
involvement of the SPRET/Ei X chromosome in the response to
LPS.
To exclude the involvement of sex hormones in LPS
resistance, we first compared the LPS resistance in ovariecto-
mized (ovx) (BxS)F1 mice with their sham operated (BxS)F12013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 457
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3counterparts. After injection with 500mg of LPS, all ovx and
sham operated mice survived, showing no significant differ-
ences in body temperature and IL6 levels (p¼ 0.9781)
(Supporting Information Fig. S2A and B; IL6). A similar
experiment was performed on males to examine the possible
role of testosterone in sensitizing (BxS)F1 males for LPS by
injecting castrated (orchiectomy) and sham operated mice with
500mg of LPS. Mortality, body temperature (Supporting
Information Fig. S2C) and serum IL6 levels (Supporting
Information Fig S2D; p¼ 0.5228) were not significantly different
between the two groups. These findings exclude a role of sex
hormones in the higher LPS resistance of (BxS)F1 females
relative to (BxS)F1 males.
Identification of Tsc22d3 as a candidate gene
We previously described the important role of the GR in
mediating the LPS resistance of SPRET/Ei mice (Dejager et al,
2010b). Therefore, we focused on 41 putative in silico predicted
GRE-genes located in a10 cM region flanking the X-located QTL
peak (Supporting Information Table 1). Next, ChIP-Seq analysis,
studying the binding of GR to DNA upon dexamethasone (Dex)
stimulation of mouse hepatoma cells, identified Tsc22d3 as the
only GC-inducible gene in this QTL region (Fig 2A). Additionally,
ChIP analysis of liver lysates confirmed that GR binds
significantly to a GRE element in the promoter of Tsc22d3 of
C57BL/6 and SPRET/Ei mice (Fig 2B; p¼ 0.0442 and p¼ 0.0492,
respectively). Given the considerable anti-inflammatory potential
of Gilz (Ayroldi et al, 2001; Mittelstadt & Ashwell, 2001), we
hypothesized thatTsc22d3 is the causative gene underlying the X-
located QTL for LPS resistance. Previously, we reported higher
expression levels of Gilz in livers of SPRET/Ei mice compared to
C57BL/6 mice (Dejager et al, 2010b). Here, we investigated Gilz
mRNA and protein levels in unstimulated samples of liver and
lung from (BxS)F1 mice and found that the levels of Gilz mRNA,
total (p¼ 0.0007 in liver samples; p¼ 0.0012 in lung samples) as
well as of the different isoforms (p¼ 0.0028 and p¼ 0.0176 in the
liver samples), were significantly higher in females than in males
(Fig 2C). The protein levels reflected the Gilz expression levelsFigure 1. SPRET/Ei LPS resistance is genetically linked to the distal region of
significances were calculated using Mann Whitney test. ,  and  represent P
A. QTLmapping of survival after LPS challenge in 140 backcross mice. Linkage sc
analysis indicates that two loci, on chromosomes 2 and X, contain a QTL conf
maps to D2Mit510 (–log10(P)¼3.49, Wald test), amarker located at 65 cM (1
marker DXMit135 (–log10(P)¼ 3.4, Wald test) located at 69 cM (161 Mb), w
B. (BxS)F1 females are more resistant to LPS than their male counterparts. Fema
i.p. with 500mg of LPS and body temperature was monitored. This experim
representative experiment are shown here.
C. Serum IL6 levels after LPS injection in (BxS)F1mice are lower in females. Bloo
6 (n¼ 10) mice 6 h after i.p. injection with 500mg of LPS. The data in grap
D. After LPS injection, (BxS)F1 females produce lower levels of pro-inflammatory
and males (n¼5) were injected i.p. with 500mg of LPS and blood was coll
Ratios> 1.0 indicate higher levels of cytokines and chemokines in F1 male
E. LPS-stimulated bone marrow derived macrophages (BMDM) (n¼6) derived
males and C57BL/6 mice. This experiment was performed at least 3 times;
F–G. (SxB)F1 males are more resistant to LPS than (BxS)F1 males. (SxB)F1 males (n
temperature was monitored. (F). Blood was collected 6 h after LPS challenge a
(G) were derived from 1 experiment due to a lack of (SxB)F1 male mice.
EMBO Mol Med (2013) 5, 456–470 (Fig 2D; p¼ 0.0352 in liver and p¼ 0.0410 in lung). Expression
analysis of the genes located on the X chromosome close to the
Tsc22d3 gene showed that only the levels of Gilz were
significantly increased in (BxS)F1 females compared to (BxS)F1
males (p¼ 0.0296) (Fig 2E), ensuring that X inactivation escape
was not the cause of the increased Gilz expression levels in
(BxS)F1 females.
Increased Gilz levels in female (BxS)F1 mice are associated
with a sequence variation in the Tsc22d3 locus on
chromosome X
We previously reported that the higher levels of Gilz mRNA in
SPRET/Ei mice compared to C57BL/6 mice can be partly
attributed to a sequence variant in the GR gene, resulting in
increased GR activity and levels (Dejager et al, 2010b). In this
study, GR expression levels were significantly higher in (BxS)F1
mice than in C57BL/6 mice (Fig 3A) in unstimulated livers
(p¼ 0.0003 and p¼ 0.0014, female and male F1 mice,
respectively) and lungs (p< 0.0001 in both groups), but did
not differ between male and female (BxS)F1 mice, illustrating
that GR levels do not account for the higher Gilz levels in
(BxS)F1 females. In addition, corticosterone (CS) levels were
significantly different (p¼ 0.021) between (BxS)F1 females and
males (Fig 3B). Among rodents, females have generally higher
CS levels than males. A similar pattern was identified for
C57BL/6 female mice compared to C57BL/6 males (p¼ 0.0032)
(Fig 3B). However, this means that the higher Gilz transcript
levels in (BxS)F1 females might have been due to higher CS
levels and thus GR activity, rather than higher GR levels. To
further test dependency of higher Gilz levels in (BxS)F1 females
on GR activity, we determined the expression levels of other
GRE-genes known to be induced by CS-bound GR, Mkp1 and
G6P (glucose 6 phosphatase). (BxS)F1 females and males
displayed equal GR activity, as shown by similar expression
levels of GRE-genes in unstimulated livers and lungs (Fig 3C).
These data suggest that the difference in Gilz mRNA levels
between (BxS)F1 females and males is independent of GR
expression levels and activity.the X chromosome. In graphs (B-G) data are expressed as mean s.e. and
<0.05, P< 0.01 and P<0.001, respectively.
ores (plotted as –log10(P)) are shown according to genome position. The linkage
erring resistance to LPS in SPRET/Ei mice. On chromosome 2, the highest score
18Mb). In addition, the distal portion of the X chromosome, and specifically the
as significantly linked to this trait.
le (BxS)F1 (n¼ 6), male (BxS)F1 (n¼6) and C57BL/6 (n¼ 6) mice were injected
ent was repeated four times and we obtained similar trends. Data from one
d was obtained from female (BxS)F1 (n¼ 10), male (BxS)F1 (n¼ 10) and C57BL/
h C were repeated by three independent experiments.
cytokines and chemokines than corresponding males. (BxS)F1 females (n¼5)
ected 6 h later. The male/female ratio of the mean values was calculated.
s. The levels of these cytokines were measured once.
from (BxS)F1 females produce significantly less IL6 than BMDM from (BxS)F1
similar trends were obtained each time.
¼4) and (BxS)F1 males (n¼ 4) were injected i.p. with 500mg of LPS and body
nd serum IL6 levels were measured (G). The results indicated in graphs (F) and
2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 459
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3Linkage analysis of liver Gilz mRNA levels measured in 172
offspring, derived from a backcross between (BxS)F1 females
and C57BL/6 males, demonstrated a QTL strongly linked to
marker DXMit34 located at 63 cM on the chromosome X
(–log10(P)¼ 3.51, Wald test). Next, a marker located in the
Tsc22d3 gene and polymorphic between SPRET/Ei and C57BL/6
was added and it showed genetic linkage to Gilz mRNA levels
(–log10(P)¼ 2.47, Wald test). Note that the limited number of
backcross mice that were genotyped for this marker likely
accounts for the reduced linkage (Fig 3D). The SPRET/Ei allele
inferred an increase in Gilz expression at this QTL. The local
QTL at Tsc22d3 very likely indicates the presence of cis-acting
variant(s) contributing to the higher expression of Gilz in
SPRET/Ei compared to C57BL/6. A comparison of the full-
length sequence of the Tsc22d3 locus inMus musculus andMus
spretus showed five synonymous sequence variations and one
missense substitution (107E>Q) at the coding level. This
position is located in the PER region (proline and glutamic acid
rich domain), which is essential for Gilz-mediated NFkB
repression (Di Marco et al, 2007). It affects the three different
protein-coding isoforms of Gilz, because they share the same
C-terminal (D’Adamio et al, 1997). In addition, several other
sequence variants were found in upstream and downstream
regulatory regions (Supporting Information Fig S3).
Increased Gilz levels protect against endotoxemia
Gilz has been reported to reduce the in vitro induction of
inflammatory cytokines caused by LPS stimulation of cells
(Eddleston et al, 2007). As we found that the significantly
reduced cytokine production after LPS stimulation in SPRET/Ei
is also found at the level of macrophages (p¼ 0.0096) (Fig 1E),
we tested the causal role of Gilz in the LPS resistant phenotype of
SPRET/Ei mice by performing knock down studies, using
control and Gilz siRNA (Eddleston et al, 2007), in bone marrow
derived macrophages derived from C57BL/6 and SPRET/Ei
mice.We found that BMDM from SPRET/Ei compared to BMDMFigure 2. Gilz is the candidate LPS resistance gene on the X chromosome. In gra
using Mann Whitney test. ,  and  represent P<0.05, P<0.01 and P<0.001
A. ChIP-Seq analysis shows GR-DNA binding at GRE element in the Tsc22d3/Gilz
either were not treated (NI) or were treated for 2 hwith 106MDexamethasone
browser to visualize GR binding locations (depicted as black peaks) in both con
was uploaded to locate GRE sequences in the genome, depicted as a black line. H
is shown.
B. GR binds to the GRE element in the promoter of Gilz in livers of C57BL/6 and SP
and SPRET/Ei mice stimulated with PBS (n¼ 4) or with 200mg Dex (2 h; n¼ 3)
results are obtained from two independent experiments.
C. (BxS)F1 females exhibit higher levels of Gilz mRNA than (BxS)F1 males. Basal
unstimulated female andmale (BxS)F1mice. Gilz expression levels weremeasur
combined data from three independent experiments), the canonical isoform (T
Expression levels are expressed relative to the mean of the female F1 expres
D. (BxS)F1 females exhibit higher levels of Gilz protein than (BxS)F1 males. Basa
(n¼8) and male (n¼ 8) (BxS)F1 mice. Western blots for Gilz (15 kDa) and b-a
samples is shown), and the normalized Gilz protein levels are depicted below. T
is available for this figure in the Supporting Information.
E. Higher Gilz expression levels in (BxS)F1 females are not a consequence of escap
chromosome (61 cM, left picture) were measured in livers of unstimulated fe
performed twice and results from one representative experiment are shown.
EMBO Mol Med (2013) 5, 456–470 from C57BL/6 mice, produced significantly less (p¼ 0.0096)
IL-6 6 hours after LPS stimulation. Specific Gilz knock down
resulted in an increase in IL6 induction by LPS, both in C57BL/6
and SPRET/Ei macrophages, which annihilated the difference in
LPS-induced IL-6 between these two species (p¼ 0.8113)
(Fig 4A). This result suggests that Gilz indeed plays an essential
role in the suppression of LPS-induced inflammation in SPRET/
Ei macrophages.
An important role for Gilz as an anti-inflammatory molecule
was further proven by transfection of different Gilz pES34
plasmids, expressing the Gilz sequence of either C57BL/6 or
SPRET/Ei (107E>Q), in the mouse macrophage cell line
RAW264.7. Compared to the control plasmid, expression of
both Gilz versions resulted in significantly reduced induction of
pro-inflammatory cytokines, such as IL12, after 24 hours of LPS
stimulation (Fig 4B; p< 0.0001 and p¼ 0.0044 for C57BL/6 and
SPRET/Ei Gilz plasmids, respectively). As this reduction was
similar after transfection with both plasmids, this result suggests
that the amino acid variation present in the SPRET/Ei sequence
of Gilz does not lead to a change in specific activity of Gilz.
Furthermore, we examined whether Gilz administration by
injecting female C57BL/6 mice with Gilz-expressing plasmids
using high-pressure hydrodynamic plasmid injection, can
protect against LPS in vivo. We used the same fusion constructs
TAT-GilzB or the TAT-GilzS as in the in vitro experiments,
containing the TAT peptide followed by the Gilz cDNA sequence
from C57BL/6 and SPRET/Ei, respectively. In contrast with the
empty TAT-containing vector, both TAT-Gilz vectors reduced
mortality (Fig 4C) and IL6 serum concentrations to the same
extent (Fig 4D), indicating that the SPRET/Ei Gilz allele does not
confer extra protection against LPS. In addition, levels of Gilz
were higher in livers of mice treated with one of both TAT-Gilz
vectors compared to mice injected with the empty TAT vector
(Fig 4E). This indicates that higher levels of Gilz are correlated
with increased protection against the lethal effects of LPS.
Again, there was no difference in Gilz protein levels betweenphs (B-E), data are expressed as mean s.e. and significances were calculated
, respectively.
locus. ChIP-seq experiments were performed on hepatoma BWTG3 cells that
(Dex), a synthetic GR ligand.WIG data files were uploaded in the UCSC genome
ditions. In addition, the GRE sequence, identified using MEME motif analysis,
ere the GRE in the promoter of the gene Tsc22d3, on which liganded GR binds,
RET/Ei mice. ChIP experiments were performed on liver lysates from C57BL/6
. GR–DNA binding at a GRE located in the promoter of Gilz is shown here; the
liver (left) and lung (right) samples were collected for RNA preparation from
edwith QPCR using primers, which recognize all transcript variants (all, n¼ 27,
1, n¼4, one experiment) or the smallest isoform (T2, n¼ 4, one experiment).
sion levels.
l liver (left graph) and lung (right graph) samples were collected from female
ctin (42 kDa) are shown above (a representative gel containing some of the
hese results were repeated in at least three different experiments. Source data
e from X inactivation. mRNA levels of different closely located genes on the X
male (BxS)F1 (n¼ 5) and male (BxS)F1 (n¼ 6) mice. This experiment was
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Figure 3. High Gilz levels in F1 females are not mediated by increased GR levels or activity. The results from graphs (A-C) were repeated in at least three
different experiments. In graphs (A-D), data are expressed as mean s.e. and significances were calculated using Mann Whitney test. ,  and  represent
P<0.05, P<0.01 and P<0.001, respectively.
A. (BxS)F1 females and males have equal levels of GRmRNA, but both females and males have higher levels than C57BL/6 mice. Liver (left graph) and lung (right
graph) samples were collected for RNA preparation from female (BxS)F1 (n¼27), male (BxS)F1 (n¼27) and C57BL/6 (n¼18) mice, collected from three
independent experiments; expression levels are expressed relative to the mean of the female (BxS)F1 expression levels.
B. Female mice show increased levels of corticosterone. Corticosterone levels were measured in circulation of (BxS)F1 (n¼ 8) and C57BL/6 mice (n¼5) of both
sexes.
C. GR-transactivated genes such as Mkp1 and G6P are not differentially expressed in (BxS)F1 females and males. Liver and lung samples were collected for RNA
preparation from unstimulated female (BxS)F1 (white bars, n¼ 8), male (BxS)F1 (grey bars, n¼8) and C57BL/6 (black bars, n¼ 8) mice.
D. High levels of Gilz mRNA in SPRET/Ei mice are genetically linked to the Tsc22d3 (Gilz) locus on chromosome X. Linkage interval mapping using the GenStat
program revealed that a locus on chromosome X is strongly linked to the increased Gilz expression levels. The genome-wide significance threshold for detection
of QTL co-segregating with variation in Gilz expression was set at P¼0.05, corresponding to a threshold of –log10(P)¼ 3.086, depicted as the red line in the
graph. Only one genome-wide significant QTL was identified on chromosome X (marker DXMit34,–log10(P)¼3.51, Wald test,), at 2 cM from the Gilz (marker
Gilz, –log10(P)¼ 2.47, Wald test).
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3
464mice treated with TAT-GilzB or with TAT-GilzS (Fig 4E),
suggesting that the coding region of SPRET/Ei Gilz allele does
not contribute to increased Gilz levels in SPRET/Ei mice. These
data support that the effect from Gilz on the LPS resistance is
regulatory in origin.DISCUSSION
Sepsis remains one of the leading causes of death in intensive
care units (Vincent et al, 2006) and new therapeutic approaches
are urgently needed (Riedemann et al, 2003). We previously
showed that SPRET/Ei mice are highly resistant to the lethal
effects of LPS (Mahieu et al, 2006), as well as to certain bacterial
infections (Dejager et al, 2010a). LPS-induced lethal inflamma-
tion and bacterial infections are often used to study the
pathogenesis of sepsis (Dejager et al, 2011). We believe that
SPRET/Ei mice could be useful for gaining deeper under-
standing of the complex pathology of sepsis and for identifying
novel therapeutic possibilities.
The great genetic diversity between Mus spretus and Mus
musculus has already been instrumental in the identification of
genetic loci that contribute to resistance phenotypes of Mus
spretus-derived strains (Dejager et al, 2009), such as resistance
to infection with Salmonella typimurium (Dejager et al, 2010a)
and Yersinia pestis (Blanchet et al, 2011). Here, we identified
two QTL determining the resistance of SPRET/Ei mice to LPS,
one of which is located on the X chromosome.We confirmed the
importance of the SPRET/Ei X chromosome for LPS resistance
by two means. First, (BxS)F1 females, carrying one X
chromosome from C57BL/6 and one from SPRET/Ei, are more
resistant to LPS than their (BxS)F1 male counterparts. Second,
(SxB)F1 males, carrying a SPRET/Ei X chromosome, were more
resistant to LPS than (BxS)F1 males, carrying a X from the
C57BL/6 parent. This indicates that the X chromosome confers
part of the LPS resistance and not the Y chromosome, because
the Y chromosome contains only a few genes involvedmainly in
spermatogenesis and not in immune functions (Libert et al,Figure 4. Increased levels of Gilz protect against the lethal effects of LPS.
A,B. Gilz expression is correlated with cytokine production in macrophages. Bone-
(2 mice per genotype were used to generate BMDM) were either non-transfec
stimulated with 100 ng/ml LPS for 6 h and IL6 measured in the supernatant (
(C57BL/6 or SPRET/Ei sequence) TAT-plasmids, were overexpressed in RAW26
stimulation cells were harvested for RNA isolation and QPCR analysis of IL1
experiments and pooled data are shown here. In graphs (A) and (B), data are e
test. ,  and  represent P< 0.05, P< 0.01 and P<0.001, respectively.
C,D. Hydrodynamic injection of the pES34-TAT-Gilz vectors protects mice against
tail vein, either with a TAT-Gilz plasmid containing the coding sequence eit
plasmid (n¼ 12) as negative control. Mice were injected with 1mg plasmid
Mortality was monitored for five days, after which no further deaths occurre
, p<0.05, significances were calculated with a logrank (Mantel-Cox) test (
determined (D).
E. Hydrodynamic injection of the pES34-TAT-Gilz plasmid results in higher Gil
injection in the tail vein, either with a pES34-TAT-Gilz plasmid containing
plasmid (n¼ 5) as negative control. Four hours later, livers were isolated for p
Gilz (15 kDa) and b-actin (42 kDa) are shown above, and the normalized Gilz
intensity ratio between Gilz and b-actin, and by normalizing for gel differen
experiments were performed three times and representative results from o
 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.2010). It also is commonly believed that female sex steroids
enhance protective immune responses, whereas androgens
have been shown to render male mice more susceptible to
inflammatory insults (Knoferl et al, 2002;Wichmann et al, 1996;
Zellweger et al, 1997). However, our results are not confounded
with the effects of sex steroids because neither ovariectomy nor
castration affected the LPS response in the (BxS)F1 mice.
We recently reported that the SPRET/Ei LPS resistance
depends at least partly on GR actions. GR levels and
transcriptional activity are higher in SPRET/Ei mice than in
C57BL/6 mice (Dejager et al, 2010b). This is in agreement with
the enhanced resistance of mice with increased GR gene dosage
to endotoxic shock (Reichardt et al, 2000). The high GR mRNA
levels in SPRET/Ei mice were proven to be the result of a
sequence variation very close to the location of the GR-encoding
gene Nr3c1 on chromosome 18 (Dejager et al, 2010b). In our
study, LPS resistance did not map on chromosome 18, so high
GR levels are probably not related to LPS hyporesponsiveness.
We believe that GR actions, rather than GR levels, contribute to
the LPS resistance of SPRET/Ei mice and that a locus
downstream of the GC/GR axis in the distal region of the X
chromosome is involved. Moreover, it has been suggested that
GR-mediated protection against LPS in SPRET/Ei mice is
predominantly dependent on the transactivation properties of
the GR, rather than on its transrepression actions (Dejager et al,
2010b). It is conceivable that a GC-inducible gene contributes to
the ability of SPRET/Ei mice to suppress inflammation during
endotoxemia, as it has become clear that GR-transactivated
genes play a prominent role in the anti-inflammatory actions of
the GR (Newton & Holden, 2007). Thus, we hypothesized that a
GRE-gene located on the X chromosome mediates the GR anti-
inflammatory action. Using in silico analysis, we searched for
GRE-genes in the candidate region on the X chromosome and
found 41 GRE-containing genes. Based on ChIP-Seq analysis, we
found that only one of those 41 genes, Tsc22d3, contains a
functional GRE. Note that this analysis was performed in a
mouse hepatoma cell line and that GR-mediated actions are
strongly cell-type specific (Gross & Cidlowski, 2008). Therefore,marrow derived macrophages from C57BL/6 (n¼ 4) and SPRET/Ei (n¼ 4) mice
ted or transfected with control or Gilz siRNA. After 7 days of culture, cells were
A). Different pES34 plasmids (1mg DNA), either control TAT or Gilz-containing
4.7 macrophages (n¼5-6) and treated with PBS or 100 ng/ml LPS. 24 h after
2 (B). Results from graphs (A) and (B) were confirmed in two independent
xpressed as mean s.e. and significances were calculated usingMannWhitney
endotoxemia. Female C57BL/6 mice received a hydrodynamic injection in the
her from C57BL/6 (n¼ 18) or from SPRET/Ei (n¼ 17), or with the empty TAT
per gram of body weight followed 2h later by i.p. injection of 350mg of LPS.
d. This graph represents data combined from three independent experiments.
C). Six hours after LPS injection, blood was taken and serum IL6 levels were
z protein levels in the liver. Female C57BL/6 mice received a hydrodynamic
the C57BL/6 (n¼5) or SPRET/Ei (n¼ 5) coding sequence, or with empty TAT
rotein determination of Gilz and of b-actin for normalization. Western blots for
protein levels are depicted below. Normalization was done by calculating the
ces by taking the average intensity of repeated samples. These high-pressure
ne experiment are shown.
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genes in the critical region on the X chromosome.
We considered Tsc22d3 the obvious candidate for the LPS
resistance of SPRET/Ei mice. First, it co-locates with the QTL
identified on the X chromosome. Second, Gilz is strongly
induced by GR (D’Adamio et al, 1997; Eddleston et al, 2007;
Godot et al, 2006) and it has anti-inflammatory properties
(reviewed in (Beaulieu & Morand, 2011)). As Gilz represses
NF-kB (Di Marco et al, 2007), it contributes to the strong anti-
inflammatory actions of the GR (Berrebi et al, 2003;Mittelstadt &
Ashwell, 2001). For example, Gilz expression in airway
epithelial cells and human alveolar macrophages is protective
against LPS-induced inflammation (Eddleston et al, 2007;
Gomez et al, 2010; Hoppstadter et al, 2012). However, most
studies on Gilz were done in vitro, but the in vivo anti–
inflammatory potential of Gilz has received little attention
(Cannarile et al, 2009). Our results indicate that Gilz might also
be protective in models of acute inflammation, such as
endotoxemia.
Gilz is widely expressed in cells of the hematopoietic lineage
(Ayroldi & Riccardi, 2009) and in several murine and human
tissues (Cannarile et al, 2001) at relatively high levels under
basal conditions (Berrebi et al, 2003). We previously reported
that SPRET/Ei mice exhibit significantly higher levels of Gilz
mRNA than C57BL/6 mice. This difference in expression was
partly attributed to the high GR activity in SPRET/Ei mice, which
was demonstrated by performing adrenalectomy (Dejager et al,
2010b). This study indicated that both protein and mRNA levels
(of the two smallest isoforms (Bruscoli et al, 2010; Soundar-
arajan et al, 2007)) of Gilz are significantly higher in (BxS)F1
females than in (BxS)F1 males. Gilz protein levels followed the
same pattern of expression as their transcript, as reported by
Cannarile et al. (Cannarile et al, 2001). Several genes located in
the same cluster as Gilz showed equal expression in female and
male (BxS)F1 mice, which means that an effect of X inactivation
escape can be dismissed. Although several genes on the human
X chromosome escape inactivation (Carrel &Willard, 2005), this
is not common inmouse (Disteche, 1999). In humans, this event
generally occurs in clusters, mainly next to the PAR regions, and
next to the centromere. Many genes that escape X inactivation in
humans are subject to X inactivation in the mouse, suggesting
that X inactivation is more complete in the mouse (Disteche
et al, 2002). Additionally, Gilz levels are similar in C57BL/6
females and males, indicating that Gilz is expressed from one
allele in female mice. We believe that it is unlikely that Gilz
escapes X inactivation and sowe hypothesize that such escape is
not responsible for the higher levels in female (BxS)F1 mice.
As expected, (BxS)F1 females and males also showed no
difference in GR levels, as both sexes carry one SPRET/Ei and
one C57BL/6 GR allele (Dejager et al, 2010b). Although female
(BxS)F1 mice had slightly higher levels of corticosterone than
(BxS)F1 males, this did not confer the higher expression levels
of Gilz, because the expression of other typical GRE genes, such
asDusp1 and G6P, did not differ between the females andmales.
Therefore, we exclude a role for GR levels and activity in the
difference in Gilz levels between (BxS)F1 females and males.
However, variation in Gilz transcription levels mapped to theEMBO Mol Med (2013) 5, 456–470 Tsc22d3 locus on the X chromosome, suggesting that a cis-acting
sequence variation leads to increased transcription of Gilz.
Hence, we searched for variations in the SPRET/Ei Tsc22d3
locus based on the available Sanger sequences. Many sequence
variations (about 1 SNP every 100 bp) are expected because of
the high genetic divergence between Mus spretus and Mus
musculus (Dejager et al, 2009; Guenet & Bonhomme, 2003). In
total, we identified six SNPs in the coding sequence, one of
which leads to the substitution of the E at position 107 of the
canonical isoform by a Q in SPRET/Ei mice. The high expression
levels of Gilz mRNA can also be caused by sequence variations
in the 3’UTR, the promoter region, or any other region affecting
transcription and translation efficacy, promoter activity or exon
splicing. Note that we do not mention the sequence variants for
the other isoform and that these might also contribute to the
differences in Gilz levels. In addition, by comparing the
sequence variants in the SPRET/Ei Tsc22d3 genomic sequence
with sequences in LPS sensitive mouse strains, we found that
the variants are unique for the SPRET/Ei strain. Further
functional research is required to identify the causative
polymorphism(s) that contribute to the higher expression levels
of Gilz in SPRET/Ei.
Gilz is an important mediator of GR-driven anti-inflammatory
actions (Ayroldi & Riccardi, 2009). Evidence shows that Gilz
inhibition dampens the efficacy of GCs in different inflammatory
models. For example, Gilz siRNA abrogates the effects of GC
treatment on LPS-induced pro-inflammatory cytokines in
circulatingmonocytes collected from alcoholic hepatitis patients
(Hamdi et al, 2007), and Gilz siRNA increases disease severity in
a mouse model of arthritis (Beaulieu et al, 2010). Although
Suarez et al. recently reported that Gilz deficiency does not
affect cytokine production after LPS stimulation of macrophages
(Suarez et al, 2012), several other studies have reported the
importance of Gilz as a powerful suppressor of inflammation in
mice and in cells, such asmacrophages (Hoppstadter et al, 2012)
and airway epithelial cells (Eddleston et al, 2007) (reviewed in
(Beaulieu & Morand, 2011), (Ayroldi & Riccardi, 2009)). An
explanation for the discordant findings is currently difficult to
give. We have shown in our study by overexpression and knock
down studies in macrophages, that Gilz clearly significantly
controls the production of cytokines after LPS.
Our results indicate that a cis-acting sequence variation in the
Tsc22d3 gene leads to increased Gilz levels and contributes to
the resistance of SPRET/Ei mice to LPS. To determine whether
increased Gilz levels might have a protective role in endotox-
emia, we used pES34-TAT-Gilz expression vectors. The TAT-
Gilz fusion vector and protein have already been used in vitro
and in vivo. For example, it has been reported that TAT-Gilz
associates with p65 and p52, showing that Gilz interacts directly
with NFkB (Ayroldi et al, 2001). in vivo, TAT-Gilz protects mice
against the development of DNBS-induced colitis (Cannarile
et al, 2009). Our data indicate thatmacrophages transfectedwith
TAT-Gilz, containing either the C57BL/6 or SPRET/Ei sequence,
showed reduced cytokine production. In addition, mice treated
with pES34-TAT-Gilz plasmids become resistant to the lethal
effects of LPS due to the increased levels of Gilz. However, the
resistance of these mice is not as strong as that of SPRET/Ei mice2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 465
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466(Mahieu et al, 2006), which confirms the involvement of other
genetic loci. Note that hydrodynamic tail vein injection results in
specific uptake of plasmids in hepatocytes (Herrero et al, 2011;
Wolff & Budker, 2005). Although LPS mainly activates
macrophages and dendritic cells (Beutler & Rietschel, 2003),
a role for the liver in the response to endotoxemia is certainly
present (Heyninck et al, 2003). It was also reported by our group
that GC-induced protection against LPS-induced shock is
strongly mediated by hepatic GR (Van Bogaert et al, 2011).
Since Gilz is induced by GR, the liver is likely involved in the
protective capacities of Gilz. Moreover, administration of both
pES34-TAT-Gilz vectors encoding either the C57BL/6 or the
SPRET/Ei Gilz resulted in equal Gilz protein levels and in equal
protection against LPS, suggesting that the sequence variant
(107 E>Q) does not lead to higher Gilz levels nor to increased
specific activity of Gilz, at least under these conditions.
In conclusion, we demonstrate a new anti-inflammatory role
for Gilz in LPS-induced inflammation. This protective role of
Gilz should be tested in more relevant models of sepsis, such as
CLP (Dejager et al, 2011), but we believe that anti-inflammatory
properties of Gilz could form the basis of novel therapeutic
approaches for sepsis. Our results collectively underscore the
contribution of GR transactivation to the anti-inflammatory
effects of GR. This should be taken into account when designing
dissociating GR ligands, i.e. reducing the transactivation actions
of GR while maintaining its transrepression properties (Newton
& Holden, 2007).MATERIALS AND METHODS
Mice
C57BL/6J mice were purchased from Janvier (Le Genest-Saint-Isle,
France). SPRET/Ei mice were obtained from The Jackson Laboratories
(Bar Harbor, ME) and bred in our facility. We crossed C57BL/6 (B)
females and SPRET/Ei (S) males to obtain (BxS)F1 progeny. Genetically,
female and male (BxS)F1 mice differ only in their sex chromosomes.
The reciprocal cross, i.e. SPRET/Ei females crossed with C57BL/6 males,
was very unproductive, likely due to imprinting issues (L’Hote et al,
2010; Zechner et al, 1996). To map the loci responsible for SPRET/Ei
LPS resistance, an interspecific backcross between female (BxS)F1 mice
and C57BL/6 males was set up. The mice were kept in individually
ventilated cages under a constant dark-light cycle in a conventional
animal house and received food and water ad libitum. All mice were
used at the age of 8–12 weeks. Animal experiments were approved by
the institutional ethics committee for animal welfare of the Faculty of
Sciences, Ghent University, Belgium.
Construction and use of the pES34-TAT-Gilz vector
TAT-Gilz expression vectors were kindly provided by Dr. Carlo Riccardi
(University of Perugia, Italy). The Gilz cDNA sequence (Tsc22d3 gene)
was inserted into the TAT (transactivator of transcription) vector to
produce an in-frame fusion protein. The TAT peptide (GRKKRRQRRRPQ)
is a cell-penetrating peptide derived from the transactivator of
transcription of human immunodeficiency virus. This peptide can be
used to overcome the lipophilic barrier of the cell membrane and
deliver large molecules and small particles inside cells. The TAT-Gilz 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.construct was cloned into the prokaryotic expression vector pGEX-4T-2,
under the control of a chicken actin promoter, containing a GST
(glutathione S-transferase)-tag to produce an in-frame fusion protein.
The purified pGEX-4T-2-GST-TAT-Gilz vector was used to introduce the
SPRET/Ei variation that leads to a change from a glutamic acid (E) to a
glutamine (Q) at position 107 in the GILZ C-terminal region. This was
done by site directed mutagenesis by using the QuickChange Site-
Directed Mutagenesis kit (Stratagene). The mutated plasmid was
purified by using the Plasmid-Mini purification kit (Qiagen) and
sequenced for confirmation. Next, the TAT-Gilz fusion construct, devoid
of the GST-tag, was subcloned into the pES34 eukaryotic expression
vector by PCR and enzyme restriction. Both versions of the pES34-TAT-
Gilz were then purified and injected into mice as described below.
Endotoxemia model
LPS from Salmonella abortus equi was purchased from Sigma–Aldrich
(Saint Louis, USA). Mice were injected intraperitoneally with LPS in
0.25ml of pyrogen-free phosphate-buffered saline (PBS) and mortality
and rectal body temperature with an electronic thermometer (Comark
Electronics, Littlehampton, UK) was followed. Blood for cytokine
measurement was collected with a glass capillary tube from the retro-
orbital plexus 6 h after LPS injection. Blood was allowed to clot
overnight at 48C and serum was prepared by centrifugation at
20,000 g for 4min and frozen at 208C.
In vitro stimulation and transfection of bone marrow-derived
macrophages (BMDM) or RAW264.7 cells
Bone marrow cells were isolated from femurs and tibias of mice. To
derive macrophages, after centrifugation (5min, 1200 rpm, 48C) cells
were resuspended in 50ml DMEM (Invitrogen) supplemented with
10% fetal calf serum, 100 units/ml penicillin/streptomycin, 2mM
L-glutamine, 1mM sodium pyruvate, and 20ng/ml mouse recombinant
macrophage colony-stimulating factor. Bone marrow cells were
cultured in bacterial Petri dishes for 7 days, and every 2 days the
medium of the adherent cells was refreshed. After 7 days of
differentiation, bone marrow-derived macrophages were detached
with endotoxin- and enzyme-free cell dissociation buffer (Sigma) and
counted by trypan blue exclusion, and the final concentration was
adjusted to 106 cells/ml in DMEM medium supplemented with growth
factors. Next, macrophages (BMDM or RAW264.7) were plated out in
6-well plates at 106 cells/well, after which they were transfected with
equal volume of different siRNA (Eddleston et al, 2007) or Gilz-
containing plasmids, respectively, using lipofectamine (Sigma). Next,
cells were stimulated with LPS (100 ng/ml) and at different time
points after LPS, IL6 levels were measured in supernatant using a
bioassay (see below).
Hydrodynamic tail vein injection of plasmids
To study whether increased levels of Gilz protect against LPS, mice
were injected in the tail vein over 5 sec with a plasmid solution
(10mg/ml in sterile, endotoxin-free PBS) in a volume equivalent to
10% of the body weight. This high-pressure hydrodynamic plasmid
injection technique leads to transient expression of plasmid genes in
livers of injected mice. Two hours later, mice were treated with LPS and
deaths were monitored. Mice were injected with TAT-Gilz expression
vectors containing the Gilz coding sequence from C57BL/6 or SPRET/
Ei, or a control TAT-containing vector.EMBO Mol Med (2013) 5, 456–470
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The paper explained
PROBLEM:
Sepsis remains an important cause of death in intensive care
units despite the availability of various therapeutics, such as
glucocorticoids (GCs). The occurrence of about 750,000 cases of
severe sepsis annually in the United States alone underscores the
need for further extensive research. A commonly used model for
studying the pathogenesis of sepsis is the LPS-induced
endotoxemia model.
RESULTS:
SPRET/Ei mice, derived from the Mus spretus species, are
remarkably more resistant to LPS injection than the commonly
used laboratory C57BL/6 mice. Linkage analysis showed that the
LPS resistance of SPRET/Ei mice maps to the distal part of
chromosome X. Based on previous findings indicating that
glucocorticoid receptor (GR) activity contributes to this resis-
tance, we confirmed that Gilz is a GR-dependent gene co-locating
with the QTL on the X chromosome. Next, we showed that
increased levels of Gilz confer resistance to LPS, indicating that it
plays an important role in the protection against endotoxemia.
IMPACT:
We provide the first evidence that Gilz has a strong anti-
inflammatory role in acute inflammation. More specifically,
increased levels of Gilz enhance the protection against the
harmful effects of LPS. Gilz might turn out to be a good option for
the treatment of acute inflammatory conditions such as sepsis.Cytokine measurements
Serum IL6 was determined with a 7TD1 hybridoma cell line as
described (Vansnick et al, 1986). Serum levels of several cytokines
were measured using Luminex technology (Bio-Rad, Nazareth-Eke,
Belgium), following the manufacturer’s protocol. Data were acquired
using the Bio-Plex suspension array system (Luminex), a dual-laser,
flow-based, microplate reader system.
Ovariectomy and orchiectomy
Female (BxS)F1 mice were anesthetized with ketamine (75mg/kg) and
xylazine (10mg/kg). A small midline dorsal incision was made in the
skin, followed by flank incisions in the peritoneum. The ovaries were
exteriorized, and the vessels attached to the ovaries were ligated and
cut. Ovaries were then removed, and the peritoneum and skin were
sutured. The same procedure was used on five other (BxS)F1 females,
but ovaries were just exteriorized and then placed back (sham
controls). For orchiectomy, male (BxS)F1 mice were anesthetized and a
small abdominal incision was made in the skin and peritoneum. The
testes and connected fat pad were exteriorized. After ligation, the
arteries were cut, and the testes and epididymis were removed. Once
the procedure was completed on both sides, the peritoneum and the
skin were sutured. All animals were given antibiotics for one week.
Success of ovariectomy and orchiectomy was determined by measur-
ing estradiol and testosterone levels, respectively, by appropriate
radioimmunoassays (Diasorin; Siemens Med.)
Quantitative trait loci (QTL) mapping
Death or survival of the 140 BSB backcross offspring (61 females and
79 males) was monitored for five days after injecting with 250mg of
LPS. All backcross mice were genotyped using 87 microsatellite
markers, the genome coverage of which was assessed by their
position on the Mouse Genome Informatics database genetic
map from The Jackson Laboratory and by applying a swept radius of
20 cM.
In addition, another backcross was set up and 172 offspring were
obtained from the interspecific cross between female (BxS)F1 miceEMBO Mol Med (2013) 5, 456–470 and male C57BL/6 mice. RNA was extracted from the livers of these
mice at the age of 8 weeks. cDNA was synthesized and used for
quantitative real time PCR analysis for Gilz (see qPCR below). The loci
responsible for the increased levels of Gilz mRNA in SPRET/Ei mice
were mapped using 81 microsatellite markers. In addition, 111
offspring were genotyped at two coding synonymous single nucleotide
polymorphisms (T>C at 137075500bp and C>G at 137075502bp),
together generating a PstI restriction site (CTGGA/A> CTGCA/G) at the
SPRET/Ei Tsc22d3 allele. We made use of the Sanger sequences of the
SPRET/Ei genome (http://www.sanger.ac.uk/) to identify the sequence
variations between Mus musculus and Mus spretus at the Gilz locus.
We used linear mixed models in GenStat 14 (www.vsni.co.uk/software/
genstat/) to explore the QTL for LPS resistance and Gilz expression
levels. Gilz expression levels were log transformed before analysis. In a
preliminary search for QTL, we tested the association of individual loci
with the trait at every marker position along the genome, using the
commonly known Simple Interval Mapping (SIM) procedure. Next, we
searched for QTL at particular positions after correcting for QTL
elsewhere in the genome, that were identified in the preliminary
analysis. This procedure is commonly known as Composite Interval
Mapping (CIM). The genome-wide type I error rate for detection of QTL
co-segregating with the phenotypic trait was set to a¼0.05,
corresponding to a threshold of (–log10(P)¼3.086).
QPCR
Tissues samples were collected in RNA Later (Qiagen), and RNA was
isolated with the RNeasyMini kit (Qiagen). RNA concentration was
measured with the Nanodrop 1000 (Thermo Scientific), and cDNA was
prepared by reverse transcription with the iScript cDNA synthesis kit
(Bio-Rad). qPCR was performed using the Roche LightCycler 480
system (Applied Biosystems). Results are given as relative expression
values normalized to the geometric means of the housekeeping genes.
Western Blot analysis
The organs collected for western blotting were snap-frozen in liquid
nitrogen and kept at –208C. Later, they were homogenized in liquid2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 467
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468nitrogen and cells were lysed in 300ml of buffer containing 0.5%
NP40 to disrupt the cytoplasmic membrane. Protein concentration
was determined by using the DC Protein Assay kit (Bio-Rad). Whole
tissue lysates (30mg of lung lysate and 60mg of liver lysate) were
separated by electrophoresis in 15% gradient SDS-polyacrylamide gels
and by using Tris-tricine-SDS electrophoresis buffer (Bio-Rad). Gels
were transferred to pre-equilibrated Immun-Blot PVDF Membranes
(Bio-Rad) in Towbin buffer containing 15% methanol. Blotting was
done overnight at 10 V and 48C. Membranes were incubated for 2 h at
room temperature with primary rabbit anti-human-GILZ antibody,
which was kindly provided by Dr. Jane Eddleston and Dr. Bruce Zuraw
(University of California, San Diego), and anti-mouse b-actin antibody
(MP Biomedicals, Europe) for internal control. After washing the blots
with PBS containing 0.1% Tween-20, they were incubated for 1 h at
room temperature with anti-rabbit antibody (IRDye 800, LI 926-
32211) and anti-mouse antibody (IRDye 680, LI 926-32220,
Westburgh, The Netherlands). Normalization was done using the
Odyssey 2.1 software by calculating the intensity ratio between Gilz
and b-actin. To normalize for the difference between gels, an average
intensity of the duplicate samples was calculated per gel. A normal-
ization factor was then obtained by dividing the higher average
intensity by the lower one and used to normalize all values.
ChIP-seq in BWTG3 cells and ChIP on liver samples
BWTG3 cells were cross-linked in 1% PFA for 10min at room
temperature. The reaction was stopped with 0.125M glycine. Cells
were washed in PBS, lysed in RIPA lysis buffer, sonicated and then
immunoprecipitated with rabbit anti-GR antibody (Santa Cruz
Biotechnology). Immunoprecipitated material was collected by
centrifugation, washed, and resuspended in 200ml elution buffer
(0.5M NaHCO3, 10% SDS) supplemented with proteinase K (100mg/
ml) and incubated for 30min at room temperature. The material was
de-cross-linked by raising the incubation temperature to 658C for
16 h. The recovered DNA was purified by the PCR purification kit
(Qiagen). DNA libraries were sent to FASTERIS SA (www.fasteris.com)
for sequencing on an Illumina Genome Analyzer IIx. The data were
processed using the Illumina CASAVA 1.7 package. Regions of
transcription factor binding were identified with the MACS peak
caller. For the analysis, we selected the strongest peaks for each
experiment, i.e., peaks with a false discovery rate (FDR)<20% and a
20-fold enrichment level (reads under peak relative to control). The
peak locations were extracted and extended by 100 bp on either side.
C57BL/6 and SPRET/Ei mice were injected with PBS or 200mg Dex
(Sigma) and livers were excised 2 hours later. Liver samples were
homogenized in cold PBS and cross-linked in 2% paraformaldehyde for
10 minutes at room temperature. The reaction was stopped with 1M
glycine. Liver lysates were sonicated and then immunoprecipitated with
rabbit anti-GR antibody (5mg per IP; sc8992, Santa Cruz Biotechnol-
ogy). The material was de-cross-linked by raising the incubation time to
658C for 16 hours. The recovered DNA was purified by the PCR
purification kit (Qiagen). qPCR was performed using the Roche
LightCycler 480 system (Applied Biosystems). The Gilz primer pair were
5’-TCTTCATGCCACCATCATGT-3’ and 5’-CCTGGAACAAAGCTGGACTC-3’.
Statistics
Differences in survival rates of backcross animals were tested using a x2
test. Survival rates of (BxS)F1 progeny after injection with different LPS 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.doses were compared by Fisher’s exact test in GraphPad Prism 5.0
software (GraphPad Software, San Diego, CA, USA). Survival curves
(Kaplan-Meier plots) were compared by a logrank (Mantel-Cox) test in
GraphPad Prism. Statistical significance of differences in gene
expression as measured by qPCR, body temperature, cytokine levels
and western blot intensities was inferred from Student’s t-test or by one-
way or two-way ANOVA in GraphPad Prism. Data are expressed
as mean s.e.. ,  and  represent P<0.05, P<0.01 and
P<0.001, respectively.Author contributions
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